1.54% -0.1279

Biocryst Pharmaceuticals Inc (BCRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BCRX? Forum Prognose

Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	155.06% 406.56	159.40	163.35	145.53	131.53
Cost Of Revenue	335.39% 9.522	2.187	2.798	4.568	6.094
Gross Profit	152.55% 397.03	157.21	160.56	140.97	125.44
Operating Expenses	7.08% 136.65	127.62	130.77	119.74	129.95
Benefits Costs and Expenses	7.65% 158.54	147.26	156.87	144.78	157.53
Costs And Expenses	12.61% 146.17	129.80	133.57	124.31	136.04
Operating Income/Loss	779.95% 260.38	29.59	29.79	21.23	-4.508
Nonoperating Income/Loss	29.17% -12.37	-17.46	-23.30	-20.47	-
Income/Loss From Continuing Operations Before Tax	1,945% 248.02	12.13	6.486	0.758	-25.99
Income Tax Expense/Benefit	382.44% 2.172	-0.769	1.401	0.726	0.804
Income/Loss From Continuing Operations After Tax	1,806% 245.84	12.90	5.085	0.032	-26.80
Net Income/Loss	1,806% 245.84	12.90	5.085	0.032	-26.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.83% 0.362	210.18	209.52	208.88	0.23
Diluted Average Shares	99.89% 0.232	219.88	219.89	215.26	0.23
Basic Earnings Per Share	1,850% 1.17	0.06	0.02	-	-0.13
Diluted Earnings Per Share	1,783% 1.13	0.06	0.02	-	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.84

0.66%

RGC

$23.30

0.00%

RDY

$14.18

1.22%

NBIX

$130.01

1.75%

VTRS

$13.86

0.90%

UTHR

$537.49

1.12%